In clinical trials, the antiviral drug Paxlovid lessened instances of hospitalizations and death in high-risk COVID-19 patients by 89 percent. But some people have struggled to get a prescription due to supply chain bottlenecks and confusion over eligibility. Reset talked to an infectious disease specialist about the drug’s efficacy. Reset also spoke with a mom who fought to get the drug for her daughter.

Host: Sasha-Ann Simons

Producer: Claire Hyman